More Cover for Chronic Care: Singapore MediSave Changes That Ease Out-of-pocket Stress in 2026

Singapore’s healthcare affordability push comes amid an ageing population. The Ministry of Health (MOH) noted that with over 20% of citizens aged 65 and above, Singapore is now a super-aged society. Against this backdrop, MOH is enhancing how MediSave can be used for outpatient chronic care and preventive needs. Today, the MediSave500/700 scheme lets Singaporeans use MediSave for outpatient treatment of chronic conditions under the CDMP, plus selected vaccinations and preventive tests. It applies at polyclinics, MediSave-accredited GP clinics, and Specialist Outpatient Clinics. The scheme has a tiered structure: $700 per year for patients with complex chronic conditions requiring more intensive management, and $500 per year for other patients.

From 1 January 2027, MOH will enhance the existing limits and rename the scheme to the “MediSave Chronic and Preventive Care” scheme. The basic annual limit will rise from $500 to $700. The annual limit for patients with complex chronic conditions will rise from $700 to $1,000. MOH said these higher limits will help approximately 915,000 patients who currently use the scheme annually to better manage out-of-pocket costs for regular consultations and medications, as well as selected vaccinations and preventive tests. This planned update sits at the heart of the Singapore MediSave chronic disease enhancement 2026 story, because it links outpatient chronic disease management with prevention, and does so with clearer naming and higher withdrawal ceilings.

CDMP Expansion: Thyroid Care Added, More Conditions Studied

Alongside the MediSave changes, MOH is expanding the CDMP to include hyperthyroidism and hypothyroidism from January 2027. MOH said this provides more comprehensive support for patients with thyroid disorders. Patients diagnosed with these thyroid conditions can benefit from the enhanced MediSave Chronic and Preventive Care limit, and also receive Community Health Assist Scheme (CHAS) subsidies for ongoing treatment and management. MOH expects this to benefit more than 53,000 patients with thyroid disorders. MOH also said it is studying other chronic conditions, such as eczema, for inclusion in the CDMP, and will provide an update when ready.

It also helps to understand the current CDMP landscape. MOH’s CDMP list covers 23 chronic diseases, including diabetes mellitus and pre-diabetes, hypertension, hyperlipidemia, stroke, asthma, chronic obstructive pulmonary disease (COPD), and several mental health conditions such as major depression, schizophrenia, bipolar disorder, anxiety, and dementia. Patients can access the programme at public hospital Specialist Outpatient Clinics, polyclinics, and more than 1,250 GP clinics and private specialist clinics across Singapore. Under CDMP rules described by MOH, each MediSave claim is subject to a 15% co-payment in cash. CDMP patients who are CHAS cardholders can tap government subsidies of up to $500 per year, while Pioneer Generation or Merdeka Generation cardholders can receive special subsidies of up to $540 per year.

These outpatient-focused enhancements matter because out-of-pocket spending is a real part of the system’s cost mix. The Commonwealth Fund reported out-of-pocket spending at 25.4% of total health care spend, and noted that primary care access and chronic disease management remain a challenge, especially for those with lower incomes. In 2022, government spending accounted for 57% of health expenditure. The direction of policy is to reduce financial friction for ongoing care without losing sight of sustainability. For patients, the practical takeaway is simple: from January 2027, higher MediSave withdrawal limits and a broader CDMP scope are designed to make it easier to fund routine chronic care and selected preventive services in community and specialist outpatient settings.